These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15997842

  • 1. Enhanced oral bioavailability of breviscapine after encapsulation in a liposomal formulation.
    Zhong HJ, Deng YJ, Yang BH, Li CL, Du S.
    Pharmazie; 2005 Jun; 60(6):475-6. PubMed ID: 15997842
    [Abstract] [Full Text] [Related]

  • 2. Distribution of liposomal breviscapine in brain following intravenous injection in rats.
    Lv W, Guo J, Li J, Huang L, Ping Q.
    Int J Pharm; 2005 Dec 08; 306(1-2):99-106. PubMed ID: 16280216
    [Abstract] [Full Text] [Related]

  • 3. Multivesicular liposome formulation for the sustained delivery of breviscapine.
    Zhong H, Deng Y, Wang X, Yang B.
    Int J Pharm; 2005 Sep 14; 301(1-2):15-24. PubMed ID: 16023316
    [Abstract] [Full Text] [Related]

  • 4. Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation.
    Brocks DR, Betageri GV.
    J Pharm Pharmacol; 2002 Aug 14; 54(8):1049-53. PubMed ID: 12195818
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics of breviscapine and its beta-cyclodextrin complex in rats].
    Zhang HY, Ping QN, Guo JX, Cao F.
    Yao Xue Xue Bao; 2005 Jun 14; 40(6):563-7. PubMed ID: 16144326
    [Abstract] [Full Text] [Related]

  • 6. Preparation, characterization, and biodistribution of breviscapine proliposomes in heart.
    Fei X, Chen X, Liang G, Yue-Jian C, Hao W, Ning G, Jia-Bi Z.
    J Drug Target; 2009 Jun 14; 17(5):408-14. PubMed ID: 19555267
    [Abstract] [Full Text] [Related]

  • 7. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
    Zhou Y, Ning Q, Yu DN, Li WG, Deng J.
    J Pharm Pharmacol; 2014 Jul 14; 66(7):903-11. PubMed ID: 24697705
    [Abstract] [Full Text] [Related]

  • 8. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
    Lu JJ, Wu ZH, Ping QN.
    Yao Xue Xue Bao; 2009 Feb 14; 44(2):197-202. PubMed ID: 19408693
    [Abstract] [Full Text] [Related]

  • 9. [Preparation of self-emulsifying soft capsule and its pharmacokinetic in rats for epimedium flavonoids].
    Jiang YN, Mo HY.
    Zhong Yao Cai; 2010 May 14; 33(5):767-71. PubMed ID: 20873563
    [Abstract] [Full Text] [Related]

  • 10. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J, Chen X, Zhong D.
    Life Sci; 2005 Nov 26; 78(2):140-6. PubMed ID: 16107266
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 26; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 12. [Enhanced absorption of breviscapine photosomes in small intestine of rats].
    Tang XQ, Yang XL.
    Zhongguo Zhong Yao Za Zhi; 2005 Feb 26; 30(3):222-5. PubMed ID: 15719646
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.
    Lv W, Guo J, Ping Q, Song Y, Li J.
    Int J Pharm; 2008 Jul 09; 359(1-2):118-22. PubMed ID: 18502062
    [Abstract] [Full Text] [Related]

  • 14. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C, Fang L, Ling L, Wang Q, Liu S, Zhao L, He Z.
    Int J Pharm; 2009 Mar 31; 370(1-2):129-35. PubMed ID: 19114099
    [Abstract] [Full Text] [Related]

  • 15. Characterization, biodistribution and targeting evaluation of breviscapine lipid emulsions following intravenous injection in mice.
    Xiong F, Wang H, Chen YJ, Geng KK, Gu N, Zhu JB.
    Drug Deliv; 2011 Feb 31; 18(2):159-65. PubMed ID: 21028951
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of breviscapine in dogs and rabbits following single intravenous administration].
    Liu Q, Luo G, Wang Y, Ma Y, Zhang R.
    Zhong Yao Cai; 2005 Oct 31; 28(10):913-6. PubMed ID: 16479930
    [Abstract] [Full Text] [Related]

  • 17. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L, Geng Y, Li H, Zhang Y, You J, Chang Y.
    Pharmazie; 2009 Feb 31; 64(2):86-9. PubMed ID: 19320279
    [Abstract] [Full Text] [Related]

  • 18. A study of rivastigmine liposomes for delivery into the brain through intranasal route.
    Arumugam K, Subramanian GS, Mallayasamy SR, Averineni RK, Reddy MS, Udupa N.
    Acta Pharm; 2008 Sep 31; 58(3):287-97. PubMed ID: 19103565
    [Abstract] [Full Text] [Related]

  • 19. Preparation and pharmacokinetics in rabbits of breviscapine unilamellar vesicles.
    Lv W, Guo J, Li J, Wang X, Li J, Ping Q.
    Drug Dev Ind Pharm; 2006 Mar 31; 32(3):309-14. PubMed ID: 16556535
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system.
    Ma Y, Li H, Guan S.
    Drug Dev Ind Pharm; 2015 Feb 31; 41(2):177-82. PubMed ID: 25113432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.